| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 | Ajinomoto Bio-Pharma Services The Power to Make Ajinomoto Bio-Pharma Services is a fully integrated contract development and manufacturing organization with sites in Belgium, United States, Japan, and India providing comprehensive development, cGMP manufacturing, and aseptic fill finish services for small and large molecule APIs and intermediates. Ajinomoto Bio-Pharma Services offers a broad range of innovative platforms and capabilities for pre-clinical and pilot programs to commercial quantities, including: Corynex® protein expression technology, oligonucleotide synthesis, antibody drug conjugations (ADC), high potency APIs (HPAPI), biocatalysis, continuous flow manufacturing and more. Ajinomoto Bio-Pharma Services is dedicated to providing a high level of quality and service to meet … Type: | 0 | 0 | 0 | 775 |
 |  Akamis Bio Harnessing the Power of Tumor Gene Therapy to Turn the Tide in the Battle Against Cancer Akamis is a clinical-stage oncology company whose mission is to leverage its groundbreaking T-SIGn® platform to positively impact the lives of people living with cancer. We are developing a portfolio of solid tumor-targeted T-SIGn® therapeutics which aim to enable a patient’s own immune system to recognize, attack, and clear their cancer. Akamis’ growing pipeline of T-SIGn® therapeutics is anchored by its lead clinical-stage program, NG-350A, which is being investigated in an ongoing Phase 1 clinical study in patients with metastatic or advanced epithelial tumors. … Type: | 4 | 1 | 2 | 59 |
 |  Akari Therapeutics, Plc Developing novel advanced therapies to address unmet needs of patients with autoimmune & inflammatory diseases. Akari Therapeutics, Plc (Nasdaq: AKTX) is a biotechnology company developing advanced therapies for autoimmune and inflammatory diseases. Akari’s lead asset, investigational nomacopan, is a bispecific recombinant inhibitor of complement C5 activation and leukotriene B4 (LTB4) activity. Akari’s pipeline includes a Phase 3 clinical trial program investigating nomacopan for severe pediatric hematopoietic stem cell transplant-related thrombotic microangiopathy (HSCT-TMA). Akari has been granted Orphan Drug, Fast Track and Rare Pediatric Disease designations from the FDA for nomacopan for the treatment of pediatric HSCT-TMA and orphan drug designation … Type: | 0 | 0 | 0 | 15 |
 | Aker BioMarine ASA Aker BioMarine ASA is a biotech and Antarctic krill harvesting company dedicated to improving human and planetary health Aker BioMarine is a biotech innovator and Antarctic krill harvesting company dedicated to improving human and planetary health. The company develops krill-based ingredients for nutraceutical, aquaculture, and animal feed applications. The company’s fully transparent value chain stretches from sustainable krill harvesting in pristine Antarctic waters through its Montevideo logistics hub, Houston production plant, and all the way to customers around the world. Aker BioMarine is fully owned by Aker ASA, an industrial pioneer since its establishment in 1841. Omega-3, Krill, Biotech, and … Type: | 3 | 1 | 3 | 322 |
 | Akili Play your medicine® Welcome to Akili! At Akili, we believe there is potential for medicine to be developed, delivered and experienced in a completely different way. We’re bringing together world-class neuroscience with exceptional creativity and video game development to challenge the status quo of medicine. Our digital medicine is not delivered through a pill, but rather through a patented and captivating video game experience. Effective medicine that’s captivating and enjoyable to use – now that’s refreshing! We're continuously evaluating new technologies and are advancing a broad pipeline of programs to treat cognitive deficiency and improve symptoms associated with medical conditions … Type: | 4 | 1 | 3 | 177 |
 | Akin (formerly Children's Home Society of Washington) Our Purpose:We work to disrupt systemic and multi-generational cycles of inequity by partnering with children, families Children's Home Society of Washington and Childhaven, have merged to become Akin. This merger allows us to grow and evolve as one organization, not for the sake of size but for the scope of direct impact in our commitment and partnership to and for children, families and communities. Visit us at our new website: www.akinfamily.org. early learning, family support programs, child and family counseling, therapeutic foster care, adoption services, search and reunion, advocacy for children, and Wendy's Wonderful Kids Type: | 2 | 0 | 2 | 244 |
 | Akron Bio Powering the future of medicine Since 2006, Akron’s mission is to provide GMP-compliant materials and services that enable innovators to develop and commercialize advanced therapies. Along with its line of GMP quality cytokines, growth factors, blood-derived products, and custom media, Akron specializes in manufacturing custom plasmids and endonucleases to support viral vector and gene editing technologies. Akron’s newly opened 110,000 sq. ft. manufacturing facility operates in line with FDA 21 CFR Part 11 and Eudralex Vol 4 Annex 11 standards. Akron provides advanced therapy developers the scale, compliance, flexibility, and regulatory support to develop novel technologies from pre-clinical through to … Type: | 1 | 0 | 0 | 104 |
 | Akthelia Pharmaceuticals Modulating innate immunity to improve cancer therapy outcomes. . Akthelia Pharma is a late preclinical-stage immunotherapy company, with its HQ in Iceland, targeting a huge unmet opportunity to improve cancer and cell/organ transplant outcomes through reducing the risk of neutropenic sepsis. This potentially fatal complication of systemic anticancer treatment, where a combination of reduced neutrophil count and loss of GI integrity results in bacteremia from the patient's own microbiome, is the leading cause of death associated with chemotherapy (up to 20% mortality) -- other than disease progression. Our breakthrough patented strategy, which is supported by world-leading KOLs, is to specifically … Type: | 0 | 0 | 0 | 4 |
 | Aktiia AI-driven insights for a novel understanding and care of Hypertension At Aktiia, we're at the forefront of revolutionizing blood pressure management and comprehension globally. Harnessing cutting-edge AI-powered algorithms on top of over 300 million data points collected from more than 60,000 active users across the globe, we foster breakthroughs in hypertension comprehension and tailored patient care. Aktiia's CE-marked platform is currently available in seven European markets and approved as a medical device in 44 countries worldwide. And we continue to accelerate our efforts to achieve better health for the world. AI, hypertension, digital therapeutics, healthcare, blood pressure, and patient management Type: | 1 | 0 | 1 | 49 |
 | ALBHADES [Automatic translation follows] Analytical Solutions for Health Products 💊💉 Expert in microbiology and physico-chemistry, Albades has been supporting the health product industries (pharmaceuticals, medical devices, cosmetics), the chemical and food industries since 2001. Its analytical capabilities combined with its consulting service offer a global solution to the needs of method development and validation, process validation and quality control of raw materials, finished products and packaging. Its multiple combination of expertise positions Albhades with a complete analytical offering including inorganic chemistry, organic chemistry, NMR analyses, microbiology, cellular biology, mechanical testing, stability studies and toxicology. Its strength lies in the personalized support … Type: | 6 | 1 | 3 | 69 |
 | Albireo Pharma, Inc. On March 2, 2023, Albireo was acquired by Ipsen, strengthening Ipsen’s rare disease portfolio with promising therapeutics for pediatric and adult rare liver diseases. Albireo Pharma is a rare disease company focused on the development of novel bile acid modulators to treat pediatric and adult liver diseases. Albireo’s lead product, Bylvay, was approved by the U.S. FDA as the first drug for the treatment of pruritus in all types of progressive familial intrahepatic cholestasis (PFIC), and in Europe for the treatment of PFIC. Bylvay is also being developed to treat other rare pediatric cholestatic liver diseases with a completed Phase … Type: | 2 | 2 | 1 | 106 |
 | Aldebaran [Automatic translation follows] Aldebaran is building the first digital medical assistant certified as a medical device for patients and practitioners. Aldebaran is developing an intelligent digital medical assistant for preparing consultations, guiding and optimizing the health pathway, prevention and medical decision support. Capable of adapting to any patient and any health need, our digital medical assistant allows healthcare professionals who receive consultations to free up medical time, better take care of their patients and increase the relevance of their care. Aldebaran differentiates itself from traditional e-health players by emphasizing the ethical, scientific and technological aspects (“Deep Tech” BPI label November … Type: | 14 | 3 | 13 | 25 |
 | Alentis Therapeutics We develop breakthrough treatments for Claudin1-positive tumors and organ fibrosis Alentis Therapeutics, the Claudin-1 (CLDN1) company, is a clinical stage biotechnology company on a mission to develop first-in-class antibodies and ADCs for CLDN1+ tumors and organ fibrosis. Alentis is pioneering a novel approach to modify and reverse the course of disease progression targeting CLDN1, a previously unexploited target that plays a key role in the pathology of tumors and fibrotic diseases across multiple organs. Alentis is the only company developing potential treatments for solid cancers and fibrosis targeting CLDN1. Alentis’ portfolio of anti-CLDN1 monoclonal antibodies includes a novel class of … Type: | 6 | 0 | 0 | 59 |
 | Aleph Farms We design new ways to grow animal products, starting with Aleph Cuts, our new take on steak. Aleph Farms, an Israel-based cellular agriculture company, enhances sustainability, food security and animal welfare by diversifying the supply and decentralizing the production of quality animal proteins and fats as a complement to sustainable methods of conventional animal agriculture. Founded in 2017, the company unveiled the world’s first cultivated thin-cut beef steak in 2018, the world’s first cultivated ribeye steak in 2021, and cultivated collagen in 2022. Under its product brand, Aleph Cuts, the company is launching its first product, the cultivated Petit Steak, … Type: | 16 | 6 | 7 | 127 |
 |  Algobiotech [Automatic translation follows] Specializing in the valorization of microalgae, Algobiotech is involved in the selection of new strains and the extraction of molecules of interest until their exploitation in cosmetic, food supplement and therapeutic applications. Algobiotech aims to develop and market innovative products derived from microalgae for the aforementioned applications. Through its membership of GENOPOLE, the leading French bio cluster in biotechnology, Algobiotech benefits from a very favorable environment for finding the right scientific and institutional partners to develop its R&D program around the identification and validation of the biological activities of molecules derived microalgae. Drawing on its intellectual property, … Type: | 0 | 0 | 0 | 1 |
 | Algorithmiq We develop advanced quantum algorithms to solve complex problems in life sciences Algorithmiq is a company developing advanced algorithms to solve complex problems in life sciences. Our mission is to revolutionise life sciences by exploiting the potential of quantum computing to solve currently inaccessible problems. We combine our expertise in quantum information, complex systems, and computational physics to develop algorithms that run on near-term quantum devices to discover new drugs and develop new materials Quantum physics, Complex networks, Quantum computing, Quantum simulations, Quantum chemistry, Quantum software, and Computational physics Type: | 7 | 0 | 7 | 37 |
 | AlgoTx AlgoTx develops novel therapeutic solutions for complex pain AlgoTherapeutix (AlgoTx) is a clinical stage biotechnology company developing targeted, first in class therapeutics for peripheral neuropathic pain. Its lead asset, ATX01, is based on a topical reformulation of amitriptyline with two lead indications of high unmet need that lead to unbearable pain in patient’s extremities and for which there are currently no viable treatment options. ATX01 targets the signaling pathways involved in the regulation of pain by inhibiting specific nociceptive sodium channel receptors. Its topical administration provides targeted pain relief from the excruciating pain in patient’s extremities for its two lead … Type: | 4 | 3 | 2 | 13 |
 | Alia Therapeutics On-target gene therapies Alia Therapeutics, the first Italian CRISPR company, is developing new therapeutic approaches to treat incurable genetic diseases. Alia’s unique CRISPR-based genome editing tools allow unprecedented specificity in modifying the genome, coupled with safe and efficient delivery into target cells. Alia’s gene editing platform overcomes relevant limitations speeding up the development of genetic medicines. Type: | 0 | 0 | 0 | 14 |
 | ALIOS Conseil - ALIOS recrute!! [Automatic translation follows] ALIOS Conseil is a CRO created in 1995 and specialized in providing experts to the health industries (Pharmaceuticals, Medical Devices and Cosmetics) Our consulting offering is structured around our 5 departments: Clinical Research, Health Product Vigilance, Medical Affairs, Regulatory Affairs and Quality Assurance. Our objective : meet your needs and support you with your issues ALIOS CONSEIL is: - A tailor-made, fast and efficient response - Motivated, experienced employees who are monitored throughout their intervention - Transparency for our customers and for our employees Contact : Website: www.aliosconseil.com Email: aliosconseil@aliosconseil.com Such. : 07 88 81 64 52 … Type: | 1 | 0 | 1 | 3 |
 | Aliri We deliver data for life > Aliri is committed to solving industry challenges by bringing innovative bioanalysis and spatial solutions to biotech and pharma, as the complexity of the drug development landscape continues to rise. Our mission is to support our customers with bringing life-saving therapies to market with speed and agility. We are focused on providing pharma and biotech companies with bioanalysis lab, spatial bioanalysis, and spatial biology solutions that will bring unique, comprehensive data to enable strategic decision making for lead optimization and strengthen regulatory submissions. MALDI Imaging, ADME analysis, Mass Spectrometry Imaging, Preclinical services, Molecular Imaging, Biodistribution, … Type: | 8 | 5 | 3 | 154 |
 | ALKemist Bio Next generation cell therapies for ALK-positive cancer patients At ALKemist Bio we are developing TCR-T cells that possess the ability to specifically target ALK antigens found on ALK-positive cancer cells, primarily focusing on non-small cell lung cancer patients. By harnessing the power of the immune system and engineering T cells to precisely recognize and combat these cancerous cells, we aim to pave the way for more effective treatments aiming at improving the standard of care. biotech, immunooncology, oncology, alkpositive, celltherapy, TCR, and ALK Type: | 0 | 0 | 0 | 2 |
 | Allevi by 3D Systems Versatile and easy-to-use 3D bioprinters and bioinks. Bring your work to life. Allevi builds tools to design and engineer with life. Our 3D bioprinters and bioinks are used by leading researchers worldwide to find solutions to humanity's most difficult problems - to cure disease, to test novel drugs, to eliminate the organ waiting list, to build with life. Founded in 2014, our mission is to make it easy to design and engineer 3D tissues. We created our desktop 3D bioprinter to be the most versatile, powerful and easy-to-use bioprinter on the market. Since our humble beginnings, we have grown to … Type: | 5 | 0 | 2 | 4 |
 | Alligator Bioscience AB Alligator Bioscience AB is a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs. Alligator’s portfolio includes several promising drug candidates, with the CD40 agonist mitazalimab as its key asset. Furthermore, Alligator is co-developing ALG.APV-527 with Aptevo Therapeutics Inc., several undisclosed molecules based on its proprietary technology platform, Neo-X-PrimeTM, and novel drug candidates based on the RUBYTM bispecific platform with Orion Corporation. Out-licensed programs include AC101/HLX22, in Phase 2 development, by Shanghai Henlius Biotech Inc. and an undisclosed target to Biotheus Inc. Alligator ́s technology platform comprises the proprietary technologies ALLIGATOR-GOLD® and FIND®. ALLIGATOR-GOLD® is a human antibody library containing more … Type: | 0 | 0 | 0 | 69 |
 | Allogene Therapeutics Allogene Therapeutics, with headquarters in South San Francisco, is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR TTM) products for cancer and autoimmune disease. For additional information on our guidelines, please visit www.allogene.com/news-center#community-guidelines Please be aware that the FBI recently issued a warning about an increased number of fake job postings for remote work employment that target applicants' personally identifiable information. All approved Allogene Therapeutics positions are accessible via the Allogene Careers page at www.allogene.com/careers. oncology, cancer, biotechnology, immunotherapy, CAR T, and autoimmune Type: | 4 | 2 | 2 | 290 |
 | ALN Implants Chirurgicaux [Automatic translation follows] ADVANCING HIGH TECHNOLOGY FOR LIFE Founded in 1997 by Mr. Alain NIGON, ALN Implants Chirurgaux is a French company manufacturing medical devices for the prevention of pulmonary embolism. A 100% “Franco-French” company, our production site is based in Bormes les Mimosas in the south of France. ALN's clients are public or private healthcare establishments located throughout the world. We have been putting our company at the service of the medical profession and patients for over 30 years. ALN Filters and Removal Kits are sold worldwide by our direct sales force, and our network of fully trained product … Type: | 1 | 1 | 0 | 12 |
 | ALPHANOSOS OneHealth/AI DeepTech discovering patentable mixes of natural ingredients preserving health and optimizing bioprecesses Alphanosos, a Green One-Health DeepTech company, uses its own Artificial Intelligence algorithms to discover, develop and market active ingredients and products based on blends of extracts from non-pharmaceutical ingredients, in particular edible plants. These active mixtures, some of which are already patented in 15 countries for their antimicrobial activities, are intended for the animal hygiene, dermocosmetics, food preservation and cosmetics sectors, bioprocess optimization and in the longer term, for functional foods and disease treatments. The company began its Research and Development (R&D) activities in mid-2015 and is … Type: | 4 | 3 | 1 | 5 |
 | Alrena Technologies [Automatic translation follows] Teleconsult from white zones and medical deserts Alrena Technologies is a startup created in 2015 by an emergency doctor and a radiocommunications specialist, both concerned by the extension of medical deserts and the extent of digital deserts in France. Together, they have developed transmission solutions (mobile and secure) capable of covering the white areas of the territory. They then coupled portable and interoperable medical devices allowing para-clinical examinations to be carried out in the field. (the healthcare professional can use his or her own medical devices, as long as they are connectable). The results obtained are transmitted … Type: | 2 | 1 | 1 | 4 |
 | ALSACHIM SAS Label your life Created in 2005, Alsachim is one of the world leaders in the synthesis of stable labeled (13C, 2H, 15N) internal standards, used in Bioanalysis studies, chemicals, building blocks and metabolites. Based on its expertise, Alsachim develops also Therapeutic Drug Monitoring devices to support hospitals and bioanalyse center to their daily work and routine operation. We supply our products to customers all over the world, spread across the chemical discipline including the pharmaceutical and biotech industry, clinical and bio-analytical CROs, and research institutions, in areas such as Health, Food and Environment. Alsachim is a Shimadzu group company, a … Type: | 2 | 2 | 0 | 49 |
 | Alternative Plants Cellular farmers using biotechnology to unlock the full potential of botanical resources. A biotech company dedicated to production of cosmetic ingredients from plant stem cells. We focus on cell cultures of endangered Nordic plants thus using plant biotechnology to make inaccessible treasures accessible. The value we provide is not only a new ingredient - our routine is scrupulous chemical characterisation and efficacy testing to deliver excellent ingredients along with a set of ready-to-use efficacy claims. Cosmetic ingredients, Plant derived active ingredients, In vitro efficacy testing, Anti-ageing ingredients, Skin whitening ingredients, Antioxidants, Plant cell culture, Organic ingredients, and Efficacy claiming Type: | 4 | 2 | 2 | 10 |
 | Altevax Biotech Altevax is developing a disruptive immunotherapy technology against cancer Altevax is developing a powerful pioneering immunotherapy technology against cancer. Its patented melanin-based technology has been proven in pre-clinical trials to boost an antigen-specific immune response with Cytotoxic T-lymphocytes (CD8+ Killer T cells), the body’s most powerful defenders. The Altevax immunotherapy technology works with a wide range of peptides. The Altevax technology is complementary to other anti-cancer immune technologies, such as anti PD1s. Altevax is developing an immunotherapy against glioblastoma, currently in advanced pre-clinical development, with Phase 1/2a expected in early 2024. Altevax's partnership with Assistance Publique Hôpitaux de Paris and … Type: | 3 | 1 | 2 | 6 |
 | altizem [Automatic translation follows] I like it 😊 🔹 We are an operational consulting company specializing in the Life Sciences sector (pharmaceutical, agri-food, medical devices, cosmetics and fine chemicals) of the MoOngy Group. We support our clients (Sanofi, Merck, Nestlé, LVMH, etc.) throughout the entire life cycle of a product, by mobilizing our engineering and pharmacist consultants. 🚀 Altizem represents annual growth of +35%, a presence throughout France and strong values built around people. 🏆 We are ChooseMyCompany HappyAtWork and ImpactIndex 2022 certified. MoOngy is Ecovadis Gold accredited 🏆 🔥 Passion, Proximity, Performance & Commitment are the values to which each … Type: | 32 | 0 | 32 | 147 |
 | AlveoGene Transforming Rare Respiratory Disease Outcomes Using Inhaled Genes Therapy AlveoGene is an innovative company focused on transforming rare respiratory disease outcomes using inhaled gene therapy. AlveoGene has been created by OSE, Harrington and OCC in partnership with six leading scientists from the world-renowned UK Respiratory Gene Therapy Consortium (GTC). The GTC was founded in 2001 to catalyse the application of pioneering research to gene therapy development and manufacturing related to cystic fibrosis and other respiratory diseases, and originated at Imperial College London and the Universities of Oxford and Edinburgh. AlveoGene has secured an exclusive licence to a proprietary and validated … Type: | 0 | 0 | 0 | 2 |
 | Alvéole Bioengineering unleashed! Tools for better cell sample preparation: better cell models for cell biology and microscopy. Created from work carried out by three research experts, Alvéole’s goal is to make the control of living cells the future of cell biology. A company specialized in devices for controlling the cellular microenvironment, Alvéole presents its first device PRIMO. Alvéole was founded in 2010 by three researchers from CNRS* in collaboration with Quattrocento, a “creator of young innovative companies” in the life sciences field that allows academic researchers to transform their inventions into commercial products. Vincent Studer (a specialist in bio-engineering), Maxime Dahan … Type: | 6 | 0 | 5 | 14 |
 | Alvotech Better Access. Better Lives. Our mission is to improve patient lives and the sustainability of the global healthcare ecosystem by broadening the availability and accessibility of biosimilars. Biopharmaceuticals, Research and Development, Biosimilars, Biotechnology, Pharmaceutical, Biogenerics, Health, Cell Line Development, Business Development, and Regulatory Type: | 0 | 0 | 0 | 893 |
 | ALYATEC Research and Expertise in Environmental Diseases ALYATEC is a CRO conducting clinical trials related to respiratory allergies. Most of the clinical trials executed by ALYATEC include a state-of-the-art environmental exposure chamber (EEC) to propose allergen challenges in controlled, reproducible, safe and standardized conditions. We also manage in-field clinical trials and take part in multicentric studies as an investigational center. We evaluate the action of all kind of solutions intended for allergic asthma and rhinoconjunctivitis: drugs, medical devices, air purifier, dietary supplements, masks ... ALYATEC is located in the University Hospital of Strasbourg (France), under the scientific and medical supervision of … Type: | 1 | 0 | 1 | 11 |
 | Alzforum Alzforum, founded in 1996, is a free, dynamic, web-based scientific community dedicated to understanding Alzheimer's disease and related disorders. Our editorial priorities are as diverse as the needs of the research community. The website reports news on the latest scientific findings from basic research to clinical trials; maintains public databases of animal models, therapeutics, genetic risk factors, and biomarkers; and holds live discussion forums to promote debate, speed the dissemination of new ideas, and break down barriers across the numerous disciplines that can contribute to the global effort to cure Alzheimer's disease. The Alzforum team of professional science writers and … Type: | 0 | 0 | 0 | 12 |
 | Alzohis Entreprise de dispositif médical de diagnostic in vitro : Noratest® In vitro diagnostic medical device Diagnostic, Innovation, Maladies neurodégénératives, Alzheimer, Neurosciences, Entreprise, and Entrepreneuriat Type: | 1 | 0 | 1 | 2 |
 | Amarin Corporation Amarin Corporation plc is a biopharmaceutical company focused on therapeutics to improve cardiovascular health. Amarin is an innovative pharmaceutical company leading a new paradigm in cardiovascular disease management. We are committed to increasing the scientific understanding of the cardiovascular risk that persists beyond traditional therapies and advancing the treatment of that risk for patients worldwide. Amarin has offices in Bridgewater, New Jersey in the United States, Dublin in Ireland, Zug in Switzerland, and other countries in Europe as well as commercial partners and suppliers around the world. For more information, visit www.amarincorp.com. See our Community Guidelines: bit.ly/2L7xEW6 Cardiovascular Type: | 1 | 0 | 1 | 456 |
 | Ambiotis Your partner to resolve inflammation Ambiotis is a pre-clinical CRO specialized in the study of inflammatory processes and the active end of inflammation, called resolution. Resolution is now recognized as the necessary biological process to stop inflammation and restore homeostasis in tissues. This recent approach makes possible to study the inflammation process in a completely innovative and differentiating way. Ambiotis proposes services adapted to pharmaceutical, dermo-cosmetic, agro- food/nutraceutical industries to evaluate the potential of their molecules at preclinical or clinical stages of development. Ambiotis thus helps them to put faster on the market more efficient and innovative compounds on immuno-inflammatory … Type: | 1 | 0 | 1 | 14 |
 | American Association for the Study of Liver Diseases (AASLD) Our mission: To advance and disseminate the science and practice of hepatology, and to promote liver health and quality The American Association for the Study of Liver Diseases (AASLD) is the nation’s premier organization of physicians, scientists, researchers, medical students, and healthcare professionals to study, prevent, and cure liver diseases. AASLD was founded in 1950 by a group of leading liver specialists to advance the field of hepatology. The mission of AASLD is to advance and disseminate the science and practice of hepatology and to promote improved liver health and quality patient care. AASLD has more than 7,000 + members … Type: | 8 | 5 | 1 | 88 |
 | American Gene™ A cell & #genetherapy company with a #gene delivery platform to develop cures to #cancer #HIV #PKU. In Phase 1 trial for #HIVcure. CEO @JeffreyGalvin. Type: | 0 | 0 | 0 | N/A |
 | Amferia Amferia kills bacteria, even resistant bacteria, without harming the body Amferia AB is a Swedish company that develops and markets new medical devices with emphasis on antibacterial products. The core focus of Amferia is to develop materials that can efficiently kill bacteria when used as medical devices, for example within wound care. Amferia is a spin-off from research performed at Chalmers University of Technology. The company was founded in 2018 and the founders of Amferia are Dr. Anand Kumar Rajasekharan, Professor Martin Andersson and Dr. Saba Atefyekta. Antibacterial materials, Antibiotic resistance, Elastomers, and Injectable Materials Type: | 0 | 0 | 0 | 8 |
 | Amgen Deutschland [Automatic translation follows] Our mission: Help patients. We use biotechnology to treat serious diseases. Amgen was founded in 1980 and is today a leading global independent biotechnology company with around 24,000 employees in almost 100 countries. As a pioneer in biotechnology, we at Amgen have four decades of experience in the research, development and production of innovative human therapeutics. We focus on diseases for which there are few or no treatment options. Millions of patients with serious illnesses worldwide benefit from our therapies every year. Our medicines are used in nephrology, cardiology, hematology, oncology, bone health and chronic inflammatory diseases. … Type: | 7 | 1 | 5 | 51 |
 | Amicus Therapeutics Our passion for making a difference unites us. We are a global, patient-dedicated biotechnology company focused on discovering, developing, and delivering high-quality medicines for people living with rare metabolic diseases. Amicus is the Latin word for friend. This name signifies our collaborative approach to developing medicines by incorporating the patient perspective every step of the way. Our company was founded by an entrepreneur who embarked on a life-long journey to transform the lives of those living with devastating conditions when two of his children were diagnosed with a rare disease. That spirit of empathy, compassion, and tenacity permeates our culture … Type: | 0 | 0 | 0 | 590 |
 | Amino Labs Make with Biology Amino Labs' mission is to make biotechnology learning and innovation accessible to teenagers, educators, and adults. Youtube: https://www.youtube.com/c/AminoLabs Education, Genetic Engineering, STEM, Hands-on Experiments, Zero to Genetic Engineering Hero, biology kits, STEAM, and science education Type: | 2 | 0 | 2 | 5 |
 | Amolyt Pharma Advancing peptides for the treatment of rare endocrine and related diseases Amolyt Pharma is building on its team’s established expertise to deliver life-changing treatments to patients suffering from rare endocrine and related diseases. Amolyt Pharma’s portfolio includes eneboparatide (AZP-3601), a long-acting PTH1 receptor agonist as a potential treatment for hypoparathyroidism, and AZP-3813, a peptide growth hormone receptor antagonist for the potential treatment of acromegaly. Amolyt Pharma aims to further expand and develop its portfolio by leveraging its global network in the field of endocrinology and with support from a strong syndicate of international investors. Hypoparathyroidism, Endocrinology, Metabolic Disease, Therapeutic Peptides, … Tags: FrenchTech2030 Type: | 9 | 8 | 1 | 62 |
 | Amparo Revolutionizing Prosthetics Amparo is redesigning prosthetic care to enhance the experience for amputees & orthopaedic technicians. We believe that prostheses for recent amputees can be improved to help people with a faster physical and psychological recovery. Using human-centred design, Amparo has developed completely new prosthetic fitting method. Our socket technology is directly moulded to the residual limb like a second skin. Our innovative materials allow the socket to be re-moulded as many times as necessary. This enables the whole recovery process to happen with only one prosthesis as it accommodates the early stump volume changes that happen after surgery. Prosthetics, … Type: | 6 | 1 | 5 | 9 |
 | AMPLY Discovery Novel Biologics. Designed by Evolution. Discovered by AI. Novel Biologics. Designed by Evolution. Discovered by AI. AMPLY Discovery uses machine learning and synthetic biology to mine vast biological data to discover novel biologic drug and nutraceutical candidates. Using a proprietary in silico and in vitro hybrid platform to discover best-in-class molecules AMPLY is helping tackle some of humankind's greatest challenges such as cancer, MDR infections and metabolic diseases. Based in Belfast, Northern Ireland. Spin out from Queen's University Belfast. Biotechnology, Anti-infectives, Drug Discovery, AI, Machine Learning, Animal Health, Healthcare, Genomics, Metagenomics, Cancer, Biologics, Metabolic Diseases, Natural Drugs, Nutraceuticals, and Bioinformatics Type: | 2 | 0 | 2 | 7 |
 | AMSBIO AMSBIO is a global supplier of research products and custom services for biological and pharmaceutical research Founded in 1987, AMS Biotechnology (AMSBIO) is recognised today as a leading company contributing to the acceleration of discovery through the provision of cutting-edge life science technology products and services for research and development in the medical, nutrition, cosmetics and energy industries. The AMSBIO range includes specialist antibodies, peptides and recombinant proteins. In addition the company is able to draw upon in-depth expertise in extracellular matrices to provide elegant solutions for studying cell motility, migration, invasion and proliferation. Widely acknowledged as experts in cell … Type: | 1 | 0 | 1 | 32 |
 | AmyPore New target, new paradigm, new strategy that address the root cause of Alzheimer, Parkinson, and other proteinopathies AmyPore is a biotechnology company based around the leading science of Pr. Nouara Yahi (University of Aix-Marseillle) and Pr. Jacques Fantini (University of Aix-Marseille and Institut Universitaire de France). Their expertise in molecular neurosciences has led to the discovery of AmyP53, a first-in-class patented nontoxic molecule which tackles a common mechanism of neurotoxicity shared by Alzheimer and Parkinson diseases. The company applies its pioneering computational discovery platform coupled with high performance lipid-protein and protein-protein binding technology and ultrasensitive Ca2+ amyloid pore reporting assay … Type: | 0 | 0 | 0 | 1 |
 | Anaconda BioMed NEXT GENERATION OF CATHETERS Health is the level of functional or metabolic efficiency of a living organism. In humans it is the ability of individuals or communities to adapt and self-manage when facing physical, mental or social challenges. Health, medical devices, stroke, and thrombectomy Type: | 3 | 0 | 0 | 29 |
 | ANAQUANT Identify and quantify your Host cell proteins thanks to our HCP profiler solution! #TechnologicalCRO #HCP ANAQUANT provides pharmaceutical and biotech companies with high quality services in detection and quantification of proteins by mass spectrometry, in order to speed up their R&D. Thanks to its unique know-how in control and validation of protein quantification, ANAQUANT is a partner of choice for customized assay development of proteins. Our expertise in performing specific and sensitive assays – from one to several dozens of proteins in a small sample volume – significantly contributes to the success of discovery and validation of biomarkers. Our proprietary … Type: | 2 | 1 | 2 | 10 |
 | Anatomics Quality Surgical Solutions Anatomics is a medical technology company that has been manufacturing high-quality medical devices, prosthetics and software solutions since 1995. Based in Melbourne Australia, Anatomics manufactures high quality patient specific implants for global distribution and in-licenses novel technology for Australian and New Zealand distribution. We strive to be recognised as a trusted and innovative provider of quality surgical products. Our mission is to work in partnership with healthcare professionals and medical device companies to provide the highest quality surgical products. We are a company of experienced and dedicated team members who strive for better surgical outcomes by initiating … Type: | 0 | 0 | 0 | 44 |
 | AnatomikModeling 3D custom made implants AnatomikModeling creates 3D custom-made implants for Reconstructive&Aesthetic Surgery, Pneumology and Maxillofacial Surgery. Our 3D custom-made implants are designed for Pectus Excavatum, Poland Syndrome and others anatomy defects like hard or soft tissues loss. Medical Devices, Reconstructive surgery, Pectus Excavatum surgery, Poland Syndrome surgery, and 3D CAD CAM Medical implants Type: | 0 | 0 | 0 | 4 |
 | Anavex Life Sciences Anavex utilizes genomic biomarkers in precision medicine to treat severe neurological disorders Anavex Life Sciences Corp. (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of novel therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders, including Alzheimer's disease, Parkinson's disease, Rett syndrome, schizophrenia and other central nervous system (CNS) diseases, pain, and various types of cancer. Anavex's lead drug candidate, ANAVEX®2-73 (blarcamesine), has successfully completed a Phase 2a and a Phase 2b/3 clinical trial for Alzheimer's disease, a Phase 2 proof-of-concept study in Parkinson's disease dementia, and both a Phase 2 and a Phase 3 study … Type: | 1 | 0 | 1 | 49 |
 | Anavo Therapeutics BV UNLOCKING THE PHOSPHATASE TARGET CLASS Anavo Therapeutics is the first company to systematically drug phosphatases, a rich target space previously considered undruggable for decades. We have attracted world-leading scientific expertise in phosphatase-driven disease biology and drug discovery to unlock the full potential of phosphatase-targeted allosteric modulators. In oncology, Anavo is developing multiple first-in-class therapeutic programs and will build on partnerships around its platform to establish a rich pipeline across several indications. Anavo is backed by blue-chip investors M Ventures, INKEF Capital, Taiho Ventures, and Bioqube Ventures. drug discovery, phospatase biology, and oncology Type: | 0 | 0 | 0 | 25 |
 | ANGANY Immunity Humanité ANGANY is an emerging, private pharmaceutical company, based in Quebec City, Canada. ANGANY has tackled the specific challenges of allergy to invent first-in class pharmaceuticals. ANGANY has developed an exclusive vaccine platform based on synthetic biology: the eBioparticle TM self-adjuvant vector. ANGANY also produces high quality, high purity allergens for diagnostic purposes. Finally, ANGANY has developed a flexible, fast and highly scalable 3rd generation plant production platform. ANGANY's vaccine approach opens the door to applications in cancer, infectious, autoimmune diseases and others. ANGANY is a Franco-Canadian collaboration led by Louis-Philippe Vézina, a renowned pharmaceutical entrepreneur. allergenes recombinants, immunotherapy, … Type: | 0 | 0 | 0 | 20 |
 | Angiodroid Automated Carbon Dioxide Angiography with Angiodroid the CO2 Injector Angiodroid SpA is an Italian innovative Company that projects and trades solutions for the medical market. Angiodroid® The CO2 Injector is our main product. It is a Carbon Dioxide (CO2) Injector for Interventional Radiology procedures and represents the perfect solution for the treatment of patients with: • Contrast Induced Nephropathy (CIN) risk • Diabetic Disease • Renal Failure • Intolerance to Iodinated contrast media The use of CO2 in Peripheral Angiography has been common practice for many decades. To date, however, it has not the proper success due to the lack … Type: | 2 | 0 | 0 | 46 |
 | Angiolutions We turn science into medicine. Angiolutions – breaking new ground in abdominal aortic aneurysm (AAA) treatment. Abdominal aortic aneurysms are threatening the lives of millions of patients around the world with no way to intercept early disease progression. Angiolutions will change that. Angiolutions is the first company to develop a therapeutic device preventing disease progression in small abdominal aortic aneurysms. Type: | 1 | 0 | 1 | 9 |
 | ANGLE The leading experts in cancer cell capture and analysis from liquid biopsies ANGLE is a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) diagnostic solutions for use in research, drug development and clinical oncology using a simple blood sample. ANGLE's FDA cleared and patent protected circulating tumour cell (CTC) harvesting technology known as the Parsortix® PC1 System enables complete downstream analysis of the sample including whole cell imaging and proteomic analysis and full genomic and transcriptomic molecular analysis. ANGLE’s commercial businesses are focusing on diagnostic products and clinical services. Diagnostic products include the Parsortix® system and associated consumables. … Type: | 1 | 1 | 0 | 158 |
 | AniCell Biotech Extending the ACTIVE life of Animals! AniCell is a biotech company that extends the ACTIVE life of animals with products generated non-invasively from the miracle of birth and used to accelerate regeneration of tissue and bone in injured animals. AniCell Video http://youtu.be/2H8qZLmNChY Cellular Biology, Regenerative Products, Stem Cells, Equine, Biotechnology, and Amnion Type: | 0 | 0 | 0 | 8 |
 | Anima Biotech Anima is a Tech.Bio company at the intersection of mRNA biology and AI. We are advancing the mRNA Lightning platform for the discovery of small molecule mRNA drugs and novel mRNA biology targets. Built from the ground up with over a decade of expertise in mRNA biology, the platform integrates mRNA biology with AI imaging technologies to visualize the entire life cycle of mRNA in cells and decode the mRNA biology underlying a disease. Utilizing millions of images from both healthy and diseased cells, we train disease-specific mRNA image analysis neural networks to recognize a disease signature, an mRNA biology … Type: | 2 | 0 | 1 | 62 |
 | Animal-Free Safety Assessment Collaboration The AFSA Collaboration works to accelerate the adoption of modern, human-relevant approaches to testing. The Animal-Free Safety Assessment (AFSA) Collaboration is a unique multi-sector partnership between non-profit, corporate, and philanthropic leaders working to advance acceptance and use of animal-free safety science as a gold standard across regulatory frameworks worldwide. AFSA brings together corporate, philanthropic and non-profit leaders who share the goal of accelerating a modern, species-relevant approach to safety assessment globally to better protect people and our planet, and hasten the replacement of animal testing. Our members cooperate on a range of educational and policy topics specific to the cosmetics, … Type: | 5 | 1 | 5 | 1 |
 | Anocca Engineered Immunity Anocca understands the complexity of T-cell biology. We have established a unique technology platform that replicates functional human cellular immunobiology and unlocks the potential of T-cell immunotherapies and vaccine strategies that leverage T-cell immunity. Anocca’s approach and proprietary technologies deliver the means to efficiently and precisely harness and manipulate T-cell immunity, enabling a range of next-generation therapies and vaccination strategies that address unmet patient need in oncology, infectious disease and autoimmunity. Today Anocca has a focus on delivering T-cell receptor-modified T-cell therapies (TCR-T) in oncology. Anocca is rapidly progressing a pipeline of novel therapeutic TCR-T candidates generated entirely … Type: | 0 | 0 | 0 | 98 |
 | ANS Biotech Our Services are as Unique as Your Discoveries ANS Biotech, a preclinical CRO dedicated to pain pharmacology, supports drug discovery and development efforts of companies involved in human and animal health, food and nutrition, by providing them with: • Clinically relevant in vivo models for successful R&D of innovative analgesics, especially in the field of inflammatory pain, neuropathic pain and visceral pain ; • Customized scientific studies meeting drug discovery and development objectives ; • Consulting activities. ANS Biotech also offers ALGOGramTM, a unique in vivo screening tool that provides a rapid and cost-effective means to systematically explore pain indications … Type: | 2 | 2 | 0 | 22 |
 | ANTABIO Developing Tomorrow's Antibacterials Antabio is a privately-held clinical-stage biopharmaceutical company developing novel and highly differentiated antibacterial treatments for drug-resistant infections due to CDC and WHO critical priority pathogens. Please visit www.antabio.com and follow us on Twitter @antabio Antibacterial drug discovery, Drug development, and Antibiotic Adjuvant Type: | 6 | 3 | 4 | 17 |
 | ANTHOGYR Creating new paths in dental implantology. About ANTHOGYR With more than 75 years of industrial expertise and experience in the dental industry, Anthogyr designs and manufactures ingenious and accessible solutions in implantology and customised prostheses for dentistes and dental laboratories. Recognised for its high quality products, Anthogyr offers the following: - implants system Axiom® Multi Level®, screw retained tooth AxIN® - customized prosthesis (digital & CAD/CAM solutions Simeda®, Initial®, guided surgery) - equipment for implantology and surgery Mont Blanc® - implantology trainings, CAMPUS Anthogyr - patient communication tools - Serenity® warranty program Both innovative and reactive, Anthogyr assists implantologists in … Type: | 4 | 1 | 4 | 238 |
 | ANTINEO Antineo aims to accompany customers in the preclinical development of novel anticancer agents. We provide services and strategic advice for preclinical development, optimal choice of in vitro and in vivo models as well as strategic input on potential indications to target in the therapeutic landscape. Développement préclinique, in vitro, ex vivo, in vivo, Preuve de concept, Expertise scientifique en pharmacologie, and Modèles à façon Type: | 2 | 1 | 2 | 11 |
 | Antiverse Engineering the future of drug discovery Antiverse is a Welsh techbio start-up specialising in antibody design for challenging drug targets, such as GPCRs and ion channels. We exist to create new enabling technologies that bring new therapies to patients to save lives. Headquartered in Cardiff, UK and with offices in Boston, MA, we combine state-of-the-art machine learning techniques and advanced cell line engineering to develop de novo antibody therapeutics. Machine Learning, Antibodies, and Drug discovery Type: | 3 | 1 | 3 | 16 |
 | Anuva Creating the world’s most diverse Genomic Bio/Data Bank to help uncover novel biological pathways for drug discovery Anuva is creating the world’s most diverse Genomic Bio/Data Bank to help uncover novel biological pathways for drug discovery. Anuva is a translational research company that is creating the most diverse Genomic Bio/Data Bank of Asian Populations, which is being utilized for research & development within the pharma industry. Our cohorts and biorepository allow for follow-on clinical and translational studies, which greatly empower drug development opportunities. IndiaCHIP, Genomics, Genomics - Emerging markets, Genomics - R&D, Genomics Data Platform, Genomics - India, bioinformatics, and … Type: | 5 | 2 | 4 | 59 |
 | AnyGenes® Since more than 10 years, AnyGenes® scientists develop and produce innovative high throughput screening products for signaling pathway analysis. These kits and reagents allow high throughput transcriptomic analysis of a large collection of signaling pathways in many species, biomarkers identification and validation, as well as validation of microarrays results. AnyGenes®, with its innovative & cost effective technologies, products and its proprietary molecular platform, helps scientists to accelerate their projects, publications, and biotech companies for drug development and biomarkers validation. Located in Paris, within Tenon Hospital in the 20th arrondissement, AnyGenes® constitutes a key player in the Biotechnology field. Supported by … Type: | 0 | 0 | 0 | 7 |
 | AOA Dx Revolutionizing early diagnosis of Ovarian Cancer AOA Dx is developing the next frontier in early-stage cancer detection for women through its pioneering work in glycolipids and proprietary biomarker technology. Our revolutionary tumor marker ganglioside platform, GlycoLocateTM, is paving the way for life-saving early cancer detection. In a first of its kind, AOA Dx is developing AKRIVIS GDTM, an early-stage liquid biopsy test for ovarian cancer, that has proven excellent sensitivity and specificity in a recent study. We foresee novel tumor biomarker gangliosides as the future for diagnosis, prognosis, monitoring, and eventually targeted therapies across multiple cancers. AOA Dx was co-founded … Type: | 2 | 0 | 2 | 31 |
 | AOBiome Therapeutics, Inc. AOBiome is focused on transforming human health by developing microbiome-based therapies for inflammatory conditions. AOBiome Therapeutics, Inc. is a Cambridge, MA-based life sciences company focused on transforming human health by developing microbiome-based therapies for local, nasal and systemic inflammatory conditions. Founded in 2012 by PatientsLikeMe founder Jamie Heywood and MIT-trained Chemical Engineer David Whitlock, AOBiome is advancing a pipeline of multiple, clinical-stage therapeutic candidates. The company's portfolio includes multiple clinical-stage programs: a completed Phase 2 study to treat patients with acne vulgaris or acne, a Phase 1b study to treat patients with pediatric eczema (atopic dermatitis), a Phase 2a study … Type: | 1 | 0 | 0 | 16 |
 | APC Europe Global Leader in Functional Proteins - Helping Animals Thrive 📣 Who is APC Europe? We are the world’s largest manufacturer of Spray-Dried Plasma, Hydrolyzed Proteins and other High-Quality Proteins. Our main goal is researching and producing feed ingredients with the best quality to enhance health and animal nutrition. APC Europe is part of the LGI Group and subsidiary of APC Inc. -Ankeny (Iowa). 🔧 What APC Europe does? At APC, we market, research and develop products principally derived from blood proteins based on customer need. We efficiently procure and manufacture safe and effective products for use in animal, with a … Type: | 2 | 1 | 1 | 67 |
 | ApconiX Nonclinical safety experts asking the right questions at the right time to make safer, more effective drugs ApconiX was formed by three AstraZeneca colleagues with the drive and ambition to create a world-renowned company known for its expertise in nonclinical safety toxicology and ion channel electrophysiology. The company is founded on the skills and experience of a growing team with a wide range of expertise in preclinical drug safety. The model for the pharmaceutical industry has evolved in recent years with large pharma reducing internal capability and outsourcing key skills to trusted partners. There are many more SMEs who also … Type: | 6 | 0 | 6 | 51 |
 | Apmonia Therapeutics Apmonia Therapeutics SAS is a biotechnology company dedicated to developing anti-cancer immunotherapy strategies. Apmonia Therapeutics SAS is a biotechnology company dedicated to developing anti-cancer immunotherapy strategies. Our innovative technological approach is to target tumors overexpressing matricellular protein thrombospondin-1 (TSP-1). Our long-term vision is to develop personalized immunotherapy approaches combining a proprietary therapeutic peptide targeting TSP-1 (namely TAX2 peptide) and a companion diagnostic kit, which may enable patient stratification for TAX2 therapy eligibility based on the monitoring of circulating TSP-1. immunologie and oncologie Type: | 13 | 6 | 10 | 16 |
 | Apodis [Automatic translation follows] Connects medicine stakeholders around the patient #GoodUsage #PatientEmpowerment #RuptureMédicaments #eHealth #IA Apodis is the mobile and web application that connects drug stakeholders around the patient to support them in the proper use and compliance with their treatment. Our vision: transform access to care by allowing the patient to become an actor in their daily health Apodis addresses two major issues for patients and our healthcare system: - Drug shortages which have continued to increase for 20 years - The misuse of medications which leads to more than 1 million days of hospitalization per year in France Concretely, … Type: | 26 | 6 | 31 | 17 |
 | Apollomics We are a biopharmaceutical company committed to the discovery and development of mono- and combination cancer therapies. Apollomics is an innovative biotechnology company committed to the discovery and development of oncology combination therapies. With operations in both the U.S. and China, we believe we are well positioned to unlock synergies by leveraging the strengths of partnerships with other biotechnology companies in the East and the West. Since our founding in 2015, under the leadership of our experienced management team with in-depth knowledge and expertise of the evolving cancer treatment landscape, we have built a pipeline of ten (10) drug candidates … Type: | 1 | 0 | 1 | 31 |
 | APOLO Biotech Developing RNA's technologies Development of RNA-based technologies to enhance the productivity of crops (mainly intensive) which are respectful towards the environment and human health. Our OGM-free technology allows us to immunize crops against specific pathogens (fungi, insects, viruses), as a sort of "vaccine". In addition, we know how to modulate crop development, its response to the environment or the accumulation of metabolites of interest by designing RNAs as exogenous bioactive molecules to modulate the activity of plant genes. Fruits, Biotech, RNA, ARN, Plants, Vegetables, and Crops Type: | 2 | 0 | 2 | 19 |
 | Apprentice.io Getting medicine to patients faster using the Tempo Manufacturing Cloud, a single platform for end-to-end production. Apprentice helps life science manufacturers get therapeutics to patients faster by providing one platform to turn molecules into medicine. Our Tempo Manufacturing Cloud accelerates the end-to-end drug product lifecycle by connecting together distributed teams and sites, helping them execute better on the shop floor, and optimizing their operations through enterprise-wide visibility. From preclinical benchtop to large-scale commercial manufacturing, Tempo keeps your global teams connected, empowered, and in sync. cell & gene therapy, life sciences, batch records, pre-clinical manufacturing, clinical manufacturing, commercial manufacturing, procedure execution, … Type: | 4 | 0 | 2 | 118 |
 | Aptamer Group We develop Optimer® binders to enable innovation across the life science industry. Aptamer Group develops Optimer® binders to enable innovation in the life science industry. Get our newsletter: https://aptamergroup.com/newsletter Research and Development, Assay Development, Custom development, Drug development, Custom reagents, Agriculture testing, Aptamers, Biomarker discovery, Affinity ligands, Environmental testing, Affinity chromatography ligands, ADCs / AOCs, QC reagents, Diagnostic tools, and Targeted delivery Type: | 3 | 0 | 3 | 41 |
 | Aptar CSP Technologies The premier active material science solutions expert that transforms ideas into market opportunities Aptar CSP Technologies is the premier active material science solutions expert that transforms ideas into market opportunities, accelerates and de-risks the product development process, and provides complete solutions that improve consumers’ and patients’ lives. We offer a complete set of services from concept ideation, to design and engineering, to product development, global production, quality control, and regulatory support that results in expedited speed-to-market. Our innovative solutions serve a variety of markets ranging from Pharmaceutical to Food Safety. Whether you need a solution to ensure product stability and … Type: | 0 | 0 | 0 | 291 |
 | APTEEUS Reconcile the time of Research with the one of Medecine APTEΞUS was created to provide clinicians and their patients suffering from orphan diseases, an innovative service of clinical biology that perfectly meets the emerging challenge of individualized medicine. APTEΞUS is engaged in patient-centric discovery of individualized treatments. Our technology allows the testing of thousands of molecules directly on primary cells sampled from patient with inborn error of metabolism. We can rapidly identify molecules that specifically correct the very molecular defect of the patient and give him a new opportunity to be cured. Type: | 0 | 0 | 0 | 9 |
 | Aqdot Limited The Supramolecular Chemistry Company Aqdot is a Cambridge (UK)-based supramolecular chemistry company with a focus and expertise in developing, licensing and selling novel proprietary products. The Aqdot Solutions part of the business works in partnership with customers to understand their challenges and develop solutions utilising the unique AqBit technology. This has the team working in areas from air filtering in transportation to delivery of therapeutics for cancer. In parallel the Aqdot Products part of the company has recently launched its own brands AqStarTM M1 and Oderase to date. Again, working with partners either on a distribution basis, or offering the … Type: | 2 | 1 | 1 | 29 |
 | AQEMIA Scale Drug Discovery with Quantum-inspired Physics and AI Aqemia is a pharmatech company using quantum physics and artificial intelligence to transform the drug discovery process. With a unique proprietary technology that preclude the use of experimental data, our pipeline scales the drug discovery process at an unprecedented pace, generating an exhaustive number of new drug candidates. We are hiring! Check our career website: https://jobs.lever.co/aqemia.com Blog Posts on: https://medium.com/aqemia drug discovery, in silico drug discovery, Pharmaceutical R&D, Artificial intelligence, HPC developer, drug hunting, software developer, quantum, and drug design Tags: FrenchTech2030 Type: | 28 | 17 | 16 | 59 |
 | AQUA Cultured Foods Indulge your seafood cravings, without the catch. 🎣 Eat your heart out. AQUA makes seafood safe again. Fins down, AQUA is earth’s most exciting fermentation-enabled protein. While AQUA seafood looks like fish, tastes like fish, and feels like fish––it’s 100% fish-free. We hyper-control the growing environment so every morsel of tuna, scallop, squid, and shellfish is flawless––and forever available to feed billions of seafoodies. alternative meat, alternative seafood, alternative protein, food tech, biotech, fermentation, and sustainability Type: | 2 | 1 | 1 | 18 |
 | Aratana Therapeutics Inc. Aratana Therapeutics is a wholly owned subsidiary of Elanco Animal Health. Aratana Therapeutics, Inc. (Nasdaq: PETX) is a pet therapeutics company focused on the development and commercialization of innovative therapeutics for dogs and cats. Our mission is to successfully develop and deliver best-in-class therapeutics, provide comprehensive service to veterinarians and serve as a collaborator of choice for human and animal health companies. We believe our therapeutics are highly differentiated, resolve recognizable needs in compelling markets and have therapeutic profiles superior to the standard of care. Our FDA-approved and commercially available therapeutics include: - A prostaglandin receptor antagonist that specifically targets … Type: | 2 | 0 | 0 | 16 |
 | Arbiom Excellence in protein Arbiom is committed to feeding the world in a sustainable and healthy way. We are mastering the feedstock flexibility, to create the next generation of fermentation products and technologies. We are able to deliver high-quality and sustainable protein ingredients by tapping into nature-based solutions. Arbiom has created two protein-rich ingredients: SylPro for feed with high protein content, excellent digestibility and outstanding palatability suitable for petfood and feed nutrition; Yusto for food which bring quality, taste and well-being to nourrish people sustainably through meat and dairy analogs and specialized nutrition. Arbiom is now focusing on its industrial deployment, … Type: | 10 | 3 | 5 | 25 |
 | Arcede Pharma Aiming to provide improved treatments for chronic respiratory diseases through new, innovative drug substances Aiming to provide improved treatments for chronic respiratory diseases through new, innovative and patent protected substances, thereby reducing suffering and ameliorating quality of life for patients. Type: | 0 | 0 | 0 | 3 |
 | ARC GROUP UK ARC Medical // ARC Rail Training // ARC Plant and Civils Training Experienced, established, trusted and proven... We are specialists in Rail Training, Plant & Civils Training, Health Safety Training and also Medicals and Drug & Alcohol Screenings. ARC has grown into a group of four companies, recognised largely as a leading Training Provider with training centres in South Wales and London. From our early beginnings as a dedicated Rail Training provider, we have evolved into a multi-faceted, national provider of: - Rail Training - Rail Apprentices - Medicals and Drug & Alcohol Screening - Occupational Health & Safety Training … Type: | 0 | 0 | 0 | 43 |
 | Archeon Medical High-Performance artificial ventilation for the EMS, Hospitals and military organizations. Archeon takes its name from the Acheron river, a tributary of the legendary Styx, which separates the world of the living from Hades, the greek mythological world of the dead. We are a french company made up of people who believe in innovation and in the great opportunities offered by deep technology and artificial intelligence to save lives. Patient Monitoring & Diagnostics, Emergency Care, Critical care devices, Medical devices, Basic & Advanced Life Support, and Cardiopulmonary Resuscitation Type: | 15 | 3 | 13 | 24 |
 | Arctoris Arctoris is a tech-enabled Contract Research Organization (CRO) headquartered in Oxford and Boston. Arctoris is a tech-enabled Contract Research Organization (CRO) headquartered in Oxford and Boston. We combine our unique automation platform, Ulysses, with a world-class team of excellent laboratory scientists to guide and rapidly progress our partners’ drug discovery programs from target to candidate. Data is the lifeblood of research, and “Better Data leads to Better Decisions”. Our excellent service is built on: 1) Data quality: generating large reproducible datasets by leveraging robotics and wet lab automation, in turn empowering improved decision-making. 2) Our world-class team of experienced scientists: … Type: | 8 | 0 | 7 | 39 |
 | Arcturus Therapeutics Global late-stage clinical messenger RNA medicines company Founded in 2013 and based in San Diego, California, Arcturus Therapeutics Holdings Inc. (Nasdaq: ARCT) is a global late-stage clinical mRNA medicines and vaccines company with enabling technologies: (i) LUNAR® lipid-mediated delivery, (ii) STARR® mRNA Technology (sa-mRNA) and (iii) mRNA drug substance along with drug product manufacturing expertise. The Company has an ongoing global collaboration for innovative mRNA vaccines with CSL Seqirus, and a joint venture in Japan, ARCALIS, focused on the manufacture of mRNA vaccines and therapeutics. Arcturus’ pipeline includes RNA therapeutic candidates to potentially treat ornithine transcarbamylase deficiency and cystic fibrosis, … Type: | 4 | 1 | 2 | 194 |
 | Arete Medical Technologies Our mission is to improve patient outcomes and healthcare efficiency, starting with chronic respiratory conditions. Chronic respiratory diseases reduce the quality of life of millions worldwide, and are a major cause of death. Health systems are increasingly strained. We believe improved care in the future can only come from more preventative and precision care. We apply advances in digital technologies and medical devices to both improve care and health system efficiency. Type: | 5 | 1 | 3 | 4 |
 | Ariceum Therapeutics Developing novel drugs for systemic targeted radiotherapy (STR) Ariceum Therapeutics is a private clinical-stage radiopharmaceutical company focused on the diagnosis and precision treatment of neuroendocrine and certain other aggressive, hard-to-treat cancers. Our lead targeted systemic radiopharmaceutical product, 177 Lu-satoreotide tetraxetan (Satoreotide), is an antagonist of the somatostatin type 2 receptor (SSTR2) which is overexpressed in many neuroendocrine tumours. We are developing satoreotide as a ‘theranostic’ pair for the combined diagnosis and targeted radionuclide treatment of neuroendocrine cancers, certain aggressive tumours and childhood cancer, which currently has few treatment options and a poor prognosis. Ariceum Therapeutics was launched in 2021, following … Type: | 1 | 1 | 1 | 34 |
 | Aridis Pharmaceuticals Leading the creation of transformative, first-in-class anti-infectives for life-threatening respiratory infections Aridis Pharmaceuticals is a late-stage clinical development company leading the creation of transformative, first-in-class anti-infectives for life-threatening respiratory infections. The company’s pipeline of novel mechanism antibacterial and antivirals, sprung from its proprietary technology platforms, are designed to combat the growing public health threat of antimicrobial resistant bacteria (AMR). Monoclonal Antibody , Infectious Disease, Cell line Engineering, Inhalation therapy Type: | 0 | 0 | 0 | 28 |
 | ArkAb ArkAb is now Bcell Design! ArkAb is now Bcell Design! Bcell Design develops and manufactures chimeric monoclonal antibodies with human-like characteristics for in vitro diagnostics. We provide a secure and reliable source of raw material as a best alternative to disease state plasma and human serum, currently used as calibrators, positive controls or quality controls. Through its technological platform, built upon 15 years’ expertise in mAb and early-stage immunotherapy development, IVD developers and manufacturers gain access to a wide range of antibodies that are immediately ready for testing in human models. Founded in 2007 and from one of the few … Type: | 0 | 0 | 0 | 1 |
 | Aroma Therapeutics Un ingrédient alimentaire innovant à base de clou de girofle pour la santé cognitive Aroma Therapeutics is a biotech company specialised in natural products for the prevention of brain diseases. Aroma Therapeutics has patented a scent diffusion technology for Olfactory Deep-Brain stimulation. In collaboration with well-known laboratories, the company is working on an ethno-botanical approach for : •babie's pain relief •memory improvement and prevention of Alzheimer Disease The company also provides tools for Brain Function & Sleep Enhancement. Santé, Aromathérapie, Phytothérapie, Extraction de plantes, Compléments alimentaires, Santé Cognitive, Senior, Nutraceutique, maladies du vieillissement, alzheimer, Médecine Traditionnelle Chinoise, and Nutraceutique Type: | 13 | 4 | 6 | 6 |
 | Array BioPharma Inc. Array BioPharma Inc. (NASDAQ: ARRY) is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Eight registration studies are currently advancing related to seven Array-owned or partnered drugs: binimetinib (MEK162), encorafenib (LGX818), selumetinib (partnered with AstraZeneca), danoprevir (partnered with Roche), ipatasertib (partnered with Genentech), larotrectinib (partnered with Loxo Oncology) and tucatinib (partnered with Cascadian Therapeutics). We have locations in Boulder, CO; Cambridge, MA; and Morrisville, NC. Small molecule drug discovery and development., oncology, biotechnology, melanoma, and colorectal cancer Type: | 0 | 0 | 0 | 117 |
 | ARRAYS FOR CELL NANODEVICES, SL - A4CELL Lab-in-a-cell-devices Dynamic film about cell sensing SPAchip® technology is based on intracellular silicon microchips printed with multiple fluorescent probes to analyse and monitor cellular pathways at real time intracellular processes. The cell-based assays based on SPAchip® are compatible with High Content Screening platforms and imaging analysers. Suspended planar arrays, single cell analysis, cell signaling, flow cytometry, vaccines, and immunothepary Type: | 0 | 0 | 0 | 17 |
SMB